Through the collaboration Biovitrum gains access to the proprietary technology platforms of Affibody molecules, as well as the unique albumin-binding technology for pharmaceuticals development. The agreement consists of
According to Gore, the Excluder AAA endoprosthesis device is an endovascular graft and stent combination that seals off the aneurysm and creates a new path for blood flow.
This second phase of the Absorb clinical trial will enroll approximately 80 patients at 10 centers in Europe, Australia and New Zealand, and will incorporate device enhancements designed
The patents represent the first issued for a family of applications focused in brachytherapy, said Cianna. According to the company, the Savi multi-catheter open architecture design allows for
This transfection device simplifies the delivery of DNA, RNA, and proteins into a wide range of mammalian cell types, especially difficult to transfect cells, such as many types
According to FluGen, the easy-to-use, disposable micro-device, roughly the size of a poker chip, painlessly delivers seasonal and pandemic influenza vaccines. The vaccine-delivery technology also may improve vaccination
VIAject is Biodel’s investigational ultra-rapid-acting injectable human insulin intended for meal-time use by people with type 1 and type 2 diabetes. The new drug application (NDA) will be
The sulfacetamide sodium topical suspension, 10% (lotion) has been determined to be therapeutically equivalent to Sanofi-Aventis’s Klaron lotion, 10%, which is indicated for the topical treatment of acne.
The Archexin Phase IIa trial is a single-arm, open-label study conducted at global sites in the US and India. Archexin will be administered in combination with gemcitabine in
Under the terms of the agreement, Aveo will receive an up-front payment and is eligible to receive milestone payments based upon the achievement of specified development goals. Biogen
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.